You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Skin conditions
  5. Psoriasis

Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people

  • Technology appraisal guidance
  • Reference number: TA455
  • Published:  12 July 2017
  • Guidance
  • Tools and resources
  • Information for the public
  • History

On this page

  1. Research recommendations
  2. Guidance into practice

Tools and resources

Tools to help you put the guidance into practice.

Research recommendations

  • Research recommendations information

Guidance into practice

  • About the Into practice guide

  • Practical steps to improving the quality of care and services using NICE guidance

Back to top